Professional experience
Since 2006, he has been Head of the Neurology Department at the Quironsalud University Hospital of Madrid and the Ruber Juan Bravo Hospital.
Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid, holds the national accreditation of Professor of Medical Sciences (issued by ANECA).
Doctor of Medicine, Complutense University of Madrid (UCM). Award for Outstanding Doctoral Thesis (UCM, 2004): Study on the relationship of human herpes virus 6 as an environmental factor in multiple sclerosis.
Membership in scientific societies
National and International Principal Investigator in Neuroscience at Quironsalud Madrid (June 2015 – present)
President of the Research Committee of the Quironsalud University Hospital of Madrid (2012 to present).
Member of the Research Committee of the San Carlos Clinical Hospital (2012-2015).
Member of the Council of the Faculty of Medicine of the Complutense University of Madrid (2011-2015).
Research and Teaching
Principal investigator of 100 national and international clinical trials.
7 FIS research projects from the Carlos III Institute of Health (the last 5 as principal investigator).
10 projects from private foundations, received on a competitive basis (7 as principal investigator).
He has authored 139 international articles with a total impact factor of 949,917 and 4,552 citations. 38 books and book chapters with an H-factor of 34 (2018).
His publications stand out in journals that have the greatest global impact on research, such as the New England Journal of Medicine and the Lancet.
Dr. Rafael Arroyo has given over 300 international and national presentations at various Congresses.
Education :
Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid and holds the national accreditation of Professor of Medical Sciences (issued by ANECA).
Pathologies
-Benign brain tumors: meningiomas and neuromas:
-Cerebral vascular malformations:
-Obsessive-compulsive disorder treatment operations:
-Operations to combat nervous anorexia:
Publications
2023 | Stereotactic radiosurgery for Kuss grade IV vestibular schwannoma in patients ≥ 65 years: a multi-institutional retrospective study Acta Neurochirurgica 165: 211–220,
2022 | Stereotactic radiosurgery for Kues grade IV vestibular schwannoma in young patients: a multi-institutional study Journal of Neuro-Oncology 160: 201–208.
2022 | Stereotactic radiosurgery versus active surveillance for asymptomatic, parafalcine, and parasagittal meningiomas: a matched cohort analysis from the IMPASSE Neurosurgery 90:750–757
2022| Active surveillance versus stereotactic radiosurgery for the treatment of patients with incident frontobasal meningioma - A subanalysis of the IMPASSE Cancers (Basel) trial. Mar 3;14(5):1300.
2022| Gamma Knife Outcomes and Recommendations and Complications: Patai fond Kuala Lumpur
2022| Radiosurgery for Mental Disorders LGKA Marsella
2022| The Role of SRS in Anorexia Nervosa ISRS Milan
2022| Expanding the indications for gamma knife radiosurgery Neuroonc and Rs Symp Malasia
2022 | Pituitary Adenoma: Conservative in Surgical Abortion Simp CUF Lisbo
Awards and certificates
2019|National Medical Prize XXI in the field of neurosurgery.
2018 | Editorial Board Member, American Journal of Psychiatry and Neurology
2015 | Factory Award torn away from the International Society of Stereotactic and Radiosurgery
2012 | Correspondent of the Real Medical Academy of Asturias.